Dhaka, Dec. 29 -- Beximco Pharmaceuticals' stock plunged 2 per cent on Sunday on the Dhaka Stock Exchange (DSE) following news that trading of the stock is set to be suspended on the London Stock Exchange on January 2 next year.

The pharmaceutical company was listed in Bangladesh in 1986, while it issued Global Depository Receipts (GDRs) on the Alternative Investment Market (AIM) of the London Stock Exchange in 2006.

A GDR is a financial instrument that represents shares of a foreign company, allowing international investors to invest in it. In the case of Beximco Pharma, trading of these GDRs in the London market will be suspended as the company failed to publish its audited annual financial report within the stipulated timeframe.

In ...